Epigenetic traits inscribed in chromatin accessibility in aged hematopoietic stem cells.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
16 05 2022
Historique:
received: 03 04 2021
accepted: 24 04 2022
entrez: 16 5 2022
pubmed: 17 5 2022
medline: 20 5 2022
Statut: epublish

Résumé

Hematopoietic stem cells (HSCs) exhibit considerable cell-intrinsic changes with age. Here, we present an integrated analysis of transcriptome and chromatin accessibility of aged HSCs and downstream progenitors. Alterations in chromatin accessibility preferentially take place in HSCs with aging, which gradually resolve with differentiation. Differentially open accessible regions (open DARs) in aged HSCs are enriched for enhancers and show enrichment of binding motifs of the STAT, ATF, and CNC family transcription factors that are activated in response to external stresses. Genes linked to open DARs show significantly higher levels of basal expression and their expression reaches significantly higher peaks after cytokine stimulation in aged HSCs than in young HSCs, suggesting that open DARs contribute to augmented transcriptional responses under stress conditions. However, a short-term stress challenge that mimics infection is not sufficient to induce persistent chromatin accessibility changes in young HSCs. These results indicate that the ongoing and/or history of exposure to external stresses may be epigenetically inscribed in HSCs to augment their responses to external stimuli.

Identifiants

pubmed: 35577813
doi: 10.1038/s41467-022-30440-2
pii: 10.1038/s41467-022-30440-2
pmc: PMC9110722
doi:

Substances chimiques

Chromatin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2691

Informations de copyright

© 2022. The Author(s).

Références

J Exp Med. 2017 Oct 2;214(10):3123-3144
pubmed: 28904110
Int J Hematol. 2019 Aug;110(2):170-178
pubmed: 30706327
Cell Stem Cell. 2013 Apr 4;12(4):413-25
pubmed: 23415915
Genome Biol. 2014;15(12):550
pubmed: 25516281
Blood. 2015 Sep 3;126(10):1172-83
pubmed: 26219303
Nat Genet. 2016 Oct;48(10):1193-203
pubmed: 27526324
Mol Cell Biol. 2017 Sep 12;37(19):
pubmed: 28674188
J Exp Med. 2017 Oct 2;214(10):2901-2913
pubmed: 28827447
Nature. 2016 Apr 21;532(7599):380-4
pubmed: 27074508
Nat Rev Gastroenterol Hepatol. 2020 Jun;17(6):323-337
pubmed: 32203403
N Engl J Med. 2014 Dec 25;371(26):2477-87
pubmed: 25426838
Nat Med. 2018 Jun;24(6):782-791
pubmed: 29736022
Nat Rev Immunol. 2020 Mar;20(3):196-202
pubmed: 31740804
J Clin Invest. 2014 Jan;124(1):24-9
pubmed: 24382386
Blood. 2021 Aug 12;138(6):439-451
pubmed: 33876187
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Trends Mol Med. 2019 Jun;25(6):494-515
pubmed: 31109796
Nat Med. 1996 Sep;2(9):1011-6
pubmed: 8782459
Nat Rev Cancer. 2012 Sep;12(9):599-612
pubmed: 22898539
J Exp Med. 2011 Dec 19;208(13):2691-703
pubmed: 22110168
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10592-7
pubmed: 25002492
Cell. 2018 May 31;173(6):1535-1548.e16
pubmed: 29706549
Science. 2019 Nov 1;366(6465):
pubmed: 31672865
Nat Rev Mol Cell Biol. 2019 May;20(5):303-320
pubmed: 30745579
Genes Cells. 2012 Apr;17(4):249-63
pubmed: 22380515
Cell Stem Cell. 2014 Oct 2;15(4):507-522
pubmed: 25158935
Cell. 2017 Feb 23;168(5):944-945
pubmed: 28235203
NPJ Precis Oncol. 2019 Mar 6;3:7
pubmed: 30854468
Cancer Discov. 2019 Aug;9(8):1080-1101
pubmed: 31085557
Cell Stem Cell. 2015 Jul 2;17(1):35-46
pubmed: 26095048
J Exp Med. 2016 Oct 17;213(11):2259-2267
pubmed: 27811054
Cell Stem Cell. 2014 May 1;14(5):673-88
pubmed: 24792119
Immunity. 2021 Jan 12;54(1):32-43
pubmed: 33220235
Nat Rev Immunol. 2020 Jun;20(6):375-388
pubmed: 32132681
Blood. 2013 May 23;121(21):4257-64
pubmed: 23476050
Blood. 2017 Feb 9;129(6):667-679
pubmed: 28028029
Blood. 2015 Jun 4;125(23):3542-50
pubmed: 25833962
Trends Biochem Sci. 2014 Apr;39(4):199-218
pubmed: 24647116
Adv Genet. 2010;70:277-308
pubmed: 20920752
Blood. 2017 Jul 6;130(1):23-29
pubmed: 28483764
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Stem Cell Reports. 2019 Mar 5;12(3):584-596
pubmed: 30799276
Proc Jpn Acad Ser B Phys Biol Sci. 2020;96(3):107-121
pubmed: 32161209
Inflamm Regen. 2020 Nov 5;40(1):29
pubmed: 33292805
Leukemia. 2019 Dec;33(12):2779-2794
pubmed: 31673113
Cell Stem Cell. 2020 May 7;26(5):657-674.e8
pubmed: 32169166
Blood. 2015 Jul 2;126(1):9-16
pubmed: 25931582
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33231616

Auteurs

Naoki Itokawa (N)

Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Motohiko Oshima (M)

Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Shuhei Koide (S)

Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Naoya Takayama (N)

Department of Regenerative Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Wakako Kuribayashi (W)

Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Yaeko Nakajima-Takagi (Y)

Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Kazumasa Aoyama (K)

Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Satoshi Yamazaki (S)

Division of Stem Cell Biology, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Laboratory of Stem Cell Therapy, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.

Kiyoshi Yamaguchi (K)

Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Yoichi Furukawa (Y)

Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Koji Eto (K)

Department of Regenerative Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

Atsushi Iwama (A)

Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan. 03aiwama@ims.u-tokyo.ac.jp.
Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. 03aiwama@ims.u-tokyo.ac.jp.
Laboratoty of Cellular and Molecular Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. 03aiwama@ims.u-tokyo.ac.jp.

Articles similaires

A key role for P2RX5 in brown adipocyte differentiation and energy homeostasis.

Maria Razzoli, Seth McGonigle, Bhavani Shankar Sahu et al.
1.00
Animals Adipocytes, Brown Mice Cell Differentiation Male
Animals Epigenesis, Genetic DNA Methylation Skates, Fish CpG Islands
Schizosaccharomyces Meiosis Schizosaccharomyces pombe Proteins Mitosis Epigenesis, Genetic

Classifications MeSH